| Protocol Number |
Title |
1996CG033
|
CALGB 8461 Cytogenetic studies in acute leukemia |
1996LS132
|
Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase MT1982-12 |
1999LS060
|
MT1999-14 Unrelated or partially matched allogeneic donor stem cells for lymphoma, myeloma, and chronic lymphocytic leukemia |
2000LS040
|
MT2000-12 Busulfan, Cyclophosphamide, and Melphalan Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Hematological Malignancies |
2001LS049
|
MT2001-02: Allogeneic Transplant for Hematological Malignancy |
2001LS058
|
MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy |
2002LS014
|
Hematopoietic Stem Cell Transplantation in High Risk Patients with Fanconi Anemia MT2002-02 |
2002LS032
|
MT1999-06: Vaccination with Tetanus Toxoid and Keyhold Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses |
2003NT028
|
COG AALL03B1: Classification of Acute Lymphoblastic Leukemia |
2004CG009
|
COG AALL0232 "HighRisk B-precursor Acute Lymphoblastic Leukemia" |
2004LS006
|
MT2003-15 Use of Cyclophosphamide/Fludarabine to Promote in vivo Expansion of Donor Lymphocyte Infusion s(DLI) to Enhance Efficacy after Allogeneic Transplant |
2004LS034
|
MT2004-03: A Dose Escalation Study of CD4+ CD25+ Cells in Adult Patients Undergoing HLA-Identical Sibling Donor Peripheral Blood Progenitor Cell (PBPC) Transplantation" MT2004-03: A Clinical Trial of Adult CD4+ CD25+ Regulatory T Cells in BMT Recipients |
2004LS042
|
MT2003-23: Reduced Intensity Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Supplemented with Donor Natural Killer (NK) Cell Infusions in Patients with High Risk Myeloid Malignancies who are Unsuitable for Fully Myeloablative Transplantation with a Phase II, Open Label Study of Bortezomib in the Preparative Regimen |
2004UC035
|
MT2004-04: A Multicenter, Prospective Trial to Evaluate the Role of NK Cell Kir Epitope Mismatch on Mortality and Disease Relapse in T-Cell Depleted Hematopoietic Stem Cell Transplantation for HLA-C Mismatch, Unrelated Donors for Myeloid Malignancies |
2005CG018
|
COG ADVL04P2: A Feasibility Pilot and Phase II Study of Chemoimmunotherapy with Epratuzumab (IND#12034) for Children with Relapsed CD22-positive Acute Lymphoblastic Leukemia (ALL) |
2005LS036
|
MT2005-02: Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Non-Myeloablative Preparative Regimen |
2005LS043
|
MT2005-10: Transplantation of Unrelated Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloblative Preparative Regimen |
2005NT026
|
AALL03N1 Understanding the Ethnic and Racial Differences in Survival Among Children with Acute Lymphoblastic Leukemia |
2006CG044
|
MT2006-18 (CTN 0402): A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophylaxis after HLA-Matched, Related Peripheral Blood Stem Cell Transplantation |
2006CG059
|
MT2006-26 COG AAML0531: A Phase III Randomized Trial of Gemtuzumab Ozogamicin Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults |
2006LS057
|
MT2006-09: Phase I Open Label, Single Arm Escalation Trial to Evaluate the Biodistribution and Safety of BU-12 in Patients with Advanced Leukemia |
2006NT036
|
MT2007-16R Pilot Study of Vascular Function During Hematopoietic Cell Transplantation |
2007CG034
|
COG AALL0434: Intensified Methotrexate, Nelarabine and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) |
2007CG045
|
Erwinase Master Treatment Protocol (erwinia asparaginase) |
2007CG051
|
CALGB 10602: A randomized phase II trial of azacytidine with or without the histone deacetylase inhibitor entinostat for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukemia (dysplastic type), and acute myeloid leukemia with multilineage dysplasia. |
2007CG058
|
COG AALL0433: Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies |
2007LS064
|
MT2007-12: Allogeneic Natural Killer Cells with Rituximab in Patients with CD20 Positive Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia ALSO -- Strategies to Increase Sensitivity of CLL Tumor Cells to Natural Killer Cell-Immune-Mediated Cytolysis |
2007NT079
|
Neurocognitive and White Matter Changes in Adult Allogeneic Non-myeloblative Hematopoietic Cell Transplant Survivors: A Pilot Study |
2007NT102
|
COG AALL05B1: A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Samples. |
2007NT123
|
2007-18R: Chronic GVHD Cohort Protocol |
2007NT151
|
Quality of Life in Survivors of Non-Hodgkins Lymphoma |
2008CG046
|
CALGB 10403 An Intergroup Phase II Clinical Trial for Adolescents and Young Adults with Untreated Acute Lymphoblastic Leukemia |
2008CG050
|
COG AALL07P2 Pharmacology and Toxicity of Erwinia Asparaginase (Erwinase; Cristantaspase; IND 290) Following Allergy to PEG-Asparaginase in Treatment of Children with Acute Lymphoblastic Leukemia (ALL) |
2008CG125
|
COG AAML07P1 A Phase II Pilot Study of Bortezomib (PS-341, Velcade) Combined with Reinduction Chemotherapy in Children and Young Adults with Recurrent, Refractory or Secondary Acute Myeloid Leukemia |
2008CG153
|
MT2008-42: Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response |
2008LS044
|
MT2008-06R: Phase II Trial of Velcade Plus Vorinostat in the Treatment of High Risk MDS and Relapsed/Refractory AML |
2008LS110
|
MT2008-36: Haploidentical Donor NK Cell Adoptive Therapy and Double T Cell Depleted Umbilical Cord Blood Transplantation With Post-Transplant IL-2 Immune Therapy For Refractory Acute Myeloid Leukemia
|
2008LS112
|
A Therapeutic Trial of Decitabine (Dacogen) and Vorinostat (SAHA) in Combination with Chemotherapy (Vincristine, Prednisone, Doxorubicin and PEG-Asparaginase) for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) MT2008-29R |
2008LS139
|
MT2008-38: A Phase I Trial to Determine Safety and Tolerability of Ex Vivo Expanded Human Myeloid Progenitor Cells (CLT-008) Infused 24 Hours Post-Transplant to Support Allogeneic Umbilical Cord Blood Transplantation for Hematologic Malignancies |
2009NTCG002
|
Pilot Study of Financial impact of Allogeneic Stem Cell Transplant |
2009UC052
|
T2005-003: A Study of Bortezomib With Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia |
MT2006-13
|
Autologous Peripheral Blood Stem Cell Transplant for Acute Non-Lymphocytic Leukemia (ANLL) |
Clinical Trials Help